Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2026-01-26 @ 10:14 PM
Study NCT ID:
NCT02315768
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2014-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.
Sponsor:
University of California, San Diego
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-30
First Submit QC Date:
None
Study First Post Date:
2014-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-07-18
Results First Submit QC Date:
None
Results First Post Date:
2025-09-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-25
Last Update Post Date:
2025-09-15
Last Update Post Date Type:
ESTIMATED